Effectiveness and safety of minocycline combination therapy for the treatment of patients with ventilator-associated pneumonia due to extensively drug- or pandrug-resistant Acinetobacter baumannii

Int J Antimicrob Agents. 2024 May;63(5):107129. doi: 10.1016/j.ijantimicag.2024.107129. Epub 2024 Mar 1.

Authors

Zoe Athanassa¹, Sofia Manioudaki¹, Irina Petsa¹, Vasiliki Koumaki², Aikaterini Sakagianni¹, Athanasios Tsakris³

Affiliations

¹ Intensive Care Unit, Sismanoglio General Hospital, 15126 Athens, Greece.
² Department of Microbiology, Medical school, National and Kapodistrian University of Athens, 11527 Athens, Greece.
³ Department of Microbiology, Medical school, National and Kapodistrian University of Athens, 11527 Athens, Greece. Electronic address: atsakris@med.uoa.gr.

PMID: 38432603
DOI: 10.1016/j.ijantimicag.2024.107129

No abstract available

Publication types

Letter

MeSH terms

Acinetobacter Infections* / drug therapy
Acinetobacter Infections* / microbiology
Acinetobacter baumannii* / drug effects
Aged
Anti-Bacterial Agents* / administration & dosage
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Multiple, Bacterial*
Drug Therapy, Combination*
Female
Humans
Male
Middle Aged
Minocycline* / therapeutic use
Pneumonia, Ventilator-Associated* / drug therapy
Pneumonia, Ventilator-Associated* / microbiology
Treatment Outcome

Substances

Anti-Bacterial Agents
Minocycline